28 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... • Disseminated Mycobacterium ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... • Disseminated Mycobacterium ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Antiretroviral Medication Names and 3-Letter Abbreviations by Class

Paul E. Sax, MD

#Antiretroviral #Medication #Names #Classification #HAART #Classes
HAART #Classes #HIV ... #AIDS #Pharmacology ... #Nomenclature #
HIV Antiretroviral Medications Cheat Sheet

NRTIs
Integrase Inhibitors
NNRTIs
PIs
Fusion Inhibitors
CCR5 Antagonist
Post Attachment Inhibitor
Combination Pills
NRTI-Sparing
Resistance Mutations Summary - https://hivdb.stanford.edu/ 

By
HIV Antiretroviral ... @kbrownmd #HIV ... #AIDS #HAART #Medications ... Naming #Cheatsheet #Nomenclature ... Classification #Pharmacology
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
HIV HAART Medications ... @serotavirus #HIV ... #AIDS #HAART #Medications ... Antiretroviral #Therapy #Pharmacology ... Classes #naming #nomenclature
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Women with in HIV-AIDS ... known to have HIV ... HumanPapillomavirus #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Infections in HIV-AIDS ... CD4 < 200: CMV, HSV ... Mycobacterial: ... CD4 > 200: Pulm embolism